Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Presse Medicale (Paris, France : 1983)|May 27, 2015
Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitisOliver Flossmann
Rheumatology (Oxford, England)|December 25, 2009
Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualinOliver Flossmann, David R W Jayne
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 21, 2015
The long-term outcomes of systemic vasculitisKerstin Westman, Oliver Flossmann, Gina Gregorini
Nature Clinical Practice. Rheumatology|July 24, 2008
Maintaining remission in a patient with vasculitisOliver Flossmann, David R W Jayne
Arthritis & Rheumatology (Hoboken, N.J.)|November 13, 2018
Effect of Disease Activity at Three and Six Months After Diagnosis on Long-Term Outcomes in Antineutrophil Cytoplasmic Antibody-Associated VasculitisSeerapani Gopaluni, Oliver Flossmann, Mark A Little, et al.
BMC Nephrology|May 14, 2020
Heavy chain deposition disease presenting with raised anti-GBM antibody levels; a case reportMichael Turner, Anna Crawford, Claire Winterbottom, et al.
Arthritis and Rheumatism|September 29, 2011
Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitisMichael Walsh, Oliver Flossmann, Annelies Berden, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2024
Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhageAglaia Chalkia, Oliver Flossmann, Rachel Jones, et al.
Pageof 4